We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current OFSA3 market cap is 1.05B. The company's latest EPS is BRL -0.9263 and P/E is -21.00.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 349.51M | 186.05M | 254.98M | 287.83M | 305.94M |
Operating Income | 63.24M | -5.5M | 25.35M | 28.06M | 32.78M |
Net Income | 46.33M | -3.4M | -70.4M | 4.12M | 19.71M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Revenue | 680.33M | 798M | 991.35M | 1.14B | 1.03B |
Operating Income | 71.8M | 104.81M | 141.11M | 177.32M | 80.7M |
Net Income | 46.28M | 89.72M | 113.96M | 130.66M | -49.98M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 1.35B | 1.31B | 1.3B | 1.27B | 1.28B |
Total Liabilities | 610.54M | 578.53M | 636.02M | 600.03M | 589.61M |
Total Equity | 735.97M | 734.25M | 664.42M | 669.57M | 689.4M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 869.54M | 1.1B | 1.19B | 1.35B | 1.28B |
Total Liabilities | 377.06M | 543.13M | 551.17M | 610.54M | 589.61M |
Total Equity | 492.48M | 560.81M | 641.47M | 735.97M | 689.4M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | 89.59M | 81.56M | 137.69M | 202.32M | 190.3M |
Investing | -78.15M | -8.24M | -16.69M | -26.17M | -37.14M |
Financing | -7.95M | -4M | -23.9M | -72.79M | -14.36M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Operating | 56.39M | 111.94M | 46.5M | 89.59M | 190.3M |
Investing | -50.4M | -23.53M | -60.41M | -78.15M | -37.14M |
Financing | -26.3M | 91.52M | -50.62M | -7.95M | -14.36M |
Market Cap | 1.05B |
Price to Earnings Ratio | -21.00 |
Price to Sales Ratio | 1.01 |
Price to Cash Ratio | 3.45 |
Price to Book Ratio | 1.52 |
Dividend Yield | 3.16% |
Shares Outstanding | 53.95M |
Average Volume (1 week) | 12k |
Average Volume (1 Month) | 5.55k |
52 Week Change | -21.02% |
52 Week High | 27.72 |
52 Week Low | 18.50 |
Spread (Intraday) | 1.7 (8.21%) |
Company Name | Ourofino S.A |
Address |
rodovia anhanguera sp 330, km 298 cravinhos, sao paulo |
Website | https://www.ourofinosaudeanimal.com |
Industry | veterinary svcs-animal specs (0742) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions